- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 39-53 of
169 results
1025 Exhibit: Imashuku et al, Management of severe neutropenia with cyclosporin ...
Document
IPR2018-01714, No. 1025-25 Exhibit - Imashuku et al, Management of severe neutropenia with cyclosporin during initial treatment of Epstein Barr virus related hemophagocytic lymphohistiocyto...
|
|
Cite Document
1004 Exhibit: Sampaio et al, Thalidomide selectively inhibits tumor necrosis factor a...
Document
IPR2018-01714, No. 1004-4 Exhibit - Sampaio et al, Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes, J Exp Med, 1733 699 703 1991 (P.T....
|
|
Cite Document
1055 Exhibit: Declaration of James L Mullins, PhD Part 4 of 5
Document
IPR2018-01714, No. 1055-58 Exhibit - Declaration of James L Mullins, PhD Part 4 of 5 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1016 Exhibit: Hideshima, et al, Thalidomide and its analogs overcome drug resistan...
Document
IPR2018-01714, No. 1016-16 Exhibit - Hideshima, et al, Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy, Blood, 962943 2950 200...
|
|
Cite Document
1042 Exhibit: Morgan J et al, Overall survival with dexamethasone in phase III mult...
Document
IPR2018-01714, No. 1042-42 Exhibit - Morgan J et al, Overall survival with dexamethasone in phase III multiple myeloma trials after adjustment for cross over to lenalidomide, Haematologica 93s...
|
|
Cite Document
1041 Exhibit: Armoiry, X, et al, Lenalidomide in the treatment of multiple myeloma a...
Document
IPR2018-01714, No. 1041-41 Exhibit - Armoiry, X, et al, Lenalidomide in the treatment of multiple myeloma a review, J Clin Pharm Ther 33219 226 2008 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1009 Exhibit: Corral et al, Differential Cytokine Modulation and T Cell Activation by T...
Document
IPR2018-01714, No. 1009-9 Exhibit - Corral et al, Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That are Potent Inhibitors of TNF ¿¿, J Im...
|
|
Cite Document
1035 Exhibit: J Blade and J Esteve, Treatment Approaches for Relapsing and Refra...
Document
IPR2018-01714, No. 1035-35 Exhibit - J Blade and J Esteve, Treatment Approaches for Relapsing and Refractory Multiple Myeloma, Acta Oncologica, 397843 847 2000 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1008 Exhibit: Muller et al, Amino substituted Thalidomide Analogues Potent Inhibito...
Document
IPR2018-01714, No. 1008-8 Exhibit - Muller et al, Amino substituted Thalidomide Analogues Potent Inhibitors of TNF ¿¿ Productions, Bioorganic Medicinal Chemistry Letters, 91625 1630 1999 (P...
|
|
Cite Document
1017 Exhibit: V T DeVita, Jr, Chapter 16 Principles of Chemotherapy, Cancer Princ...
Document
IPR2018-01714, No. 1017-17 Exhibit - V T DeVita, Jr, Chapter 16 Principles of Chemotherapy, Cancer Principles and Practice of Oncology, Fourth Edition 1993 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1028 Exhibit: US Patent No 6,281,230 the 230 Patent
Document
IPR2018-01714, No. 1028-28 Exhibit - US Patent No 6,281,230 the 230 Patent (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1030 Exhibit: Bilgrami et al, Dexamethasone, paclitaxel, etoposide, cyclophospham...
Document
IPR2018-01714, No. 1030-30 Exhibit - Bilgrami et al, Dexamethasone, paclitaxel, etoposide, cyclophosphamide d TEC and G CSF for stem cell mobilisation in multiple myeloma, Bone Marrow Tra...
|
|
Cite Document
1011 Exhibit: Rajkumar Kyle, Thalidomide in the Treatment of Plasma Cell Malignan...
Document
IPR2018-01714, No. 1011-11 Exhibit - Rajkumar Kyle, Thalidomide in the Treatment of Plasma Cell Malignancies, J of Clinical Oncology, 19163593 3595 Aug 2001 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1027 Exhibit: Pomalyst Label
Document
IPR2018-01714, No. 1027-27 Exhibit - Pomalyst Label (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1034 Exhibit: Browman et al, Modified adriamycin vincristine dexamethasone m VA...
Document
IPR2018-01714, No. 1034-34 Exhibit - Browman et al, Modified adriamycin vincristine dexamethasone m VAD in primary refractory and relapsed plasma cell myeloma an NCI Canada pilot study, ...
|
|
Cite Document
